50/50 – A must watch!
Friday, January 27th, 2012 6:04:38 by Fahad Zafar
50/50 – A must watch!
Another mind-startling picture that has rocked the viewers in recent past is 50/50. There is no reason on the earth that you can make for missing out on another masterpiece of the Hollywood productions. The jaw-dropping stories just keep coming; it was just
a time when I thought that Hollywood has created everything, they came up with this heart touching beauty.
The ever-likable Joseph Gordon-Levitt plays a 27-year-old public radio employee in Seattle who doesn’t smoke or drink, or even cross the street when the light is red—but all the same he’s diagnosed with a rare form of spinal cancer. How he and the people
around him—his girlfriend (Bryce Dallas Howard), his overprotective mother (Anjelica Huston), and most of all his best pal (Seth Rogen)—react to his illness as it progresses is the crux of the film. There’s also a green young therapist (it’s a teaching hospital,
they explain), played by Anna Kendrick, who plays a significant role in Gordon-Levitt’s ability to cope with feelings he’s never had to confront before.
There couldn’t be a more serious subject, yet Gordon-Levitt and especially Rogen (who co-produced the movie) make the comedy seem both spontaneous and organic. They do what all guys try to do by masking their emotions and using humour to deflect the real
problems that are staring them in the face. Director Jonathan Levine, who did such a good job with The Wackiness several years ago, keeps the tone of the movie on-target at every turn, which is no small achievement.
50/50 had me crying by the finale, and gave me more satisfaction than many more ambitious films I’ve seen lately. If you, or someone close to you, are dealing with a serious illness, you might not be in the mood for it, but I can’t imagine anyone doing a
better job of turning this material into a piece of uplifting entertainment.
Short URL: https://www.newspakistan.pk/?p=10777
Posted by Fahad Zafar
on Jan 27 2012. Filed under Opinion.
You can follow any responses to this entry through the RSS 2.0.
You can leave a response or trackback to this entry
